{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:05:09Z","timestamp":1780941909682,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":669,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/jto.0000000000000055","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T04:34:05Z","timestamp":1389674045000},"page":"239-247","source":"Crossref","is-referenced-by-count":33,"title":["PI3K\/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy"],"prefix":"10.1016","volume":"9","author":[{"given":"Byron K.Y.","family":"Bitanihirwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayura","family":"Meerang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Friess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soltermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Frischknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sound","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Allo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhardt","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0000000000000055_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1097\/JTO.0000000000000055_bib2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0000000000000055_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbestos-related diseases","volume":"34","author":"Stayner","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1097\/JTO.0000000000000055_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1988.6.3.527","article-title":"Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers","volume":"6","author":"Alberts","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000055_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/1010-7940(91)90142-7","article-title":"Diagnostic and therapeutic strategy in malignant pleural mesothelioma","volume":"5","author":"Branscheid","year":"1991","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1097\/JTO.0000000000000055_bib6","first-page":"660","article-title":"[Prognostic factors in diffuse malignant mesothelioma of the pleura]","volume":"43","author":"Schildge","year":"1989","journal-title":"Pneumologie"},{"key":"10.1097\/JTO.0000000000000055_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jtcvs.2013.01.039","article-title":"The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11\u201314, 2012, Boston, Mass","volume":"145","author":"Rusch","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0000000000000055_bib8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0000000000000055_bib9","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1097\/JTO.0000000000000055_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14728222.2011.644788","article-title":"Targeting the PI3K signaling pathway in cancer therapy","volume":"16","author":"Bartholomeusz","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1097\/JTO.0000000000000055_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gde.2009.11.002","article-title":"Targeting the PI3K signaling pathway in cancer","volume":"20","author":"Wong","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"10.1097\/JTO.0000000000000055_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11912-012-0227-y","article-title":"PI3K and mTOR signaling pathways in cancer: new data on targeted therapies","volume":"14","author":"Willems","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1097\/JTO.0000000000000055_bib13","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/sj.onc.1207550","article-title":"An essential role for protein synthesis in oncogenic cellular transformation","volume":"23","author":"Bader","year":"2004","journal-title":"Oncogene"},{"key":"10.1097\/JTO.0000000000000055_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1097\/JTO.0000000000000055_bib15","first-page":"204","article-title":"Interfocal heterogeneity of PTEN\/MMAC1 gene alterations in multiple metastatic prostate cancer tissues","volume":"58","author":"Suzuki","year":"1998","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0000000000000055_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6603924","article-title":"FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome","volume":"97","author":"Yoshimoto","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0000000000000055_bib17","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/0008-5472-CAN-04-3913","article-title":"PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma","volume":"65","author":"Saal","year":"2005","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0000000000000055_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-8-56","article-title":"Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival","volume":"8","author":"Sawai","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1097\/JTO.0000000000000055_bib19","first-page":"2881","article-title":"Loss of PTEN promotes tumor development in malignant melanoma","volume":"63","author":"Stahl","year":"2003","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0000000000000055_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0000000000000055_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1615\/CritRevOncog.v17.i1.60","article-title":"Targeting PI3 kinase\/AKT\/mTOR signaling in cancer","volume":"17","author":"Sheppard","year":"2012","journal-title":"Crit Rev Oncog"},{"key":"10.1097\/JTO.0000000000000055_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejcts.2007.09.045","article-title":"PTEN expression is a strong predictor of survival in mesothelioma patients","volume":"33","author":"Opitz","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1097\/JTO.0000000000000055_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","volume":"77","author":"Cedr\u00e9s","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0000000000000055_bib24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000055_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.3800736","article-title":"D2-40 and calretinin\u2014a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation","volume":"20","author":"Hinterberger","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1097\/JTO.0000000000000055_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejca.2010.09.044","article-title":"Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis","volume":"47","author":"Sidi","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0000000000000055_bib27","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0000000000000055_bib28","doi-asserted-by":"crossref","first-page":"e23205","DOI":"10.1371\/journal.pone.0023205","article-title":"Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo","volume":"6","author":"Young","year":"2011","journal-title":"PLoS One"},{"key":"10.1097\/JTO.0000000000000055_bib29","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/modpathol.3800415","article-title":"Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood","volume":"18","author":"Korshunov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1097\/JTO.0000000000000055_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"issue":"Pt 3","key":"10.1097\/JTO.0000000000000055_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1242\/jcs.022459","article-title":"The nuclear affairs of PTEN","volume":"121","author":"Planchon","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1097\/JTO.0000000000000055_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1097\/JTO.0000000000000055_bib33","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/hmg\/ddl177","article-title":"The ERK1\/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation","volume":"15","author":"Chung","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1097\/JTO.0000000000000055_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2010.12.020","article-title":"Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner","volume":"144","author":"Song","year":"2011","journal-title":"Cell"},{"key":"10.1097\/JTO.0000000000000055_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1525-1578(10)60639-3","article-title":"Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features. Comparative genomic hybridization evidence for a mesothelioma subgroup","volume":"2","author":"Krismann","year":"2000","journal-title":"J Mol Diagn"},{"key":"10.1097\/JTO.0000000000000055_bib36","doi-asserted-by":"crossref","first-page":"379685","DOI":"10.1155\/2012\/379685","article-title":"Nongenomic mechanisms of PTEN regulation","volume":"2012","author":"Fata","year":"2012","journal-title":"Int J Cell Biol"},{"key":"10.1097\/JTO.0000000000000055_bib37","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1245\/s10434-012-2318-2","article-title":"Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer","volume":"19","author":"Chen","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1097\/JTO.0000000000000055_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s13277-012-0615-9","article-title":"PTEN protein expression in malignant pleural mesothelioma","volume":"34","author":"Agarwal","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1097\/JTO.0000000000000055_bib39","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1158\/1078-0432.CCR-11-1244","article-title":"PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients","volume":"17","author":"Lotan","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0000000000000055_bib40","first-page":"853","article-title":"PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer","volume":"17","author":"Lim","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1097\/JTO.0000000000000055_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem J"},{"key":"10.1097\/JTO.0000000000000055_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","volume":"77","author":"Cedr\u00e9s","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0000000000000055_bib43","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1074\/jbc.M709698200","article-title":"Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids","volume":"283","author":"Barbone","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1097\/JTO.0000000000000055_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0046-8177(98)90043-0","article-title":"Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype","volume":"29","author":"Beer","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1097\/JTO.0000000000000055_bib45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1097\/JTO.0000000000000055_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1078\/0344-0338-00043","article-title":"Immunohistochemical MIB-1 and p27kip1 as prognostic factors in pleural mesothelioma","volume":"197","author":"Leonardo","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.1097\/JTO.0000000000000055_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2559.2000.00793.x","article-title":"MIB-1 proliferation index correlates with survival in pleural malignant mesothelioma","volume":"36","author":"Comin","year":"2000","journal-title":"Histopathology"},{"key":"10.1097\/JTO.0000000000000055_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcdb.2003.12.023","article-title":"PI3-kinase and TOR: PIKTORing cell growth","volume":"15","author":"Richardson","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1097\/JTO.0000000000000055_bib49","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2005.00.661","article-title":"Neoadjuvant trastuzumab induces apoptosis in primary breast cancers","volume":"23","author":"Mohsin","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415301957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415301957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T13:06:14Z","timestamp":1565096774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415301957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1556086415301957"],"URL":"https:\/\/doi.org\/10.1097\/jto.0000000000000055","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}